title: Onycholysis associated with capecitabine in combination with irinotecan in two patients with colorectal cancer.
authors.forename: Alberto
authors.initials: A
authors.lastname: Muñoz
authors.forename: Ramón
authors.initials: R
authors.lastname: Barceló
authors.forename: Itziar
authors.initials: I
authors.lastname: Rubio
authors.forename: Joan Manuel
authors.initials: JM
authors.lastname: Mañé
authors.forename: Josefa
authors.initials: J
authors.lastname: Ferreiro
authors.forename: Guillermo
authors.initials: G
authors.lastname: López-Vivanco
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives*; D000069287:Capecitabine; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D005472:Fluorouracil / Q000031:analogs & derivatives; D006801:Humans; D000077146:Irinotecan; D008297:Male; D008875:Middle Aged; D009260:Nail Diseases / Q000139:chemically induced*; D009262:Nails / Q000187:drug effects*
chemical_list: D003841:Deoxycytidine; D000069287:Capecitabine; D000077146:Irinotecan; D005472:Fluorouracil; D002166:Camptothecin